Back to top
more

Cardiovascular Systems, Inc. (CSII)

(Delayed Data from NSDQ)

$39.49 USD

39.49
435,746

+1.98 (5.28%)

Updated May 3, 2019 04:00 PM ET

After-Market: $39.52 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

STERIS (STE) Cuts 2017 View: Will it See Gloomy Days Ahead?

On Feb 09, we issued an updated research report on Ohio-based STERIS plc (STE).

    Mead Johnson-Reckitt Benckiser Mega Deal: A Strategic Fit?

    Pediatric nutrition manufacturer Mead Johnson Nutrition Company (MJN) recently announced an agreement to be acquired by British consumer-products maker, Reckitt Benckiser Group plc.

      NuVasive (NUVA) Beats Q4 Earnings, Revenues; Guides 2017

      NuVasive, Inc. (NUVA) reported fourth-quarter 2016 adjusted earnings per share (EPS) of 53 cents, reflecting a 51.4% surge from the year-ago quarter.

        Myriad Genetics (MYGN): Q2 Impressive, 2017 View a Drag

        On Feb 8, we issued an updated research report on Salt Lake City, UT-based molecular diagnostic company Myriad Genetics Inc. (MYGN).

          Zimmer Biomet (ZBH) Launches Subchondroplasty Procedure

          Zimmer Biomet Holdings, Inc. (ZBH), a leading player in the musculoskeletal healthcare space, recently announced the global launch of its Subchondroplasty (SCP) Procedure.

            CVS Health (CVS) Beats on Q4 Earnings, Retains '17 View

            CVS Health Corporation (CVS) reported fourth-quarter 2016 adjusted earnings per share (EPS) of $1.71, up 11.8% year over year.

              Myriad Genetics (MYGN) Beats on Q2 Earnings, Narrows View

              Myriad Genetics Inc. (MYGN) reported adjusted earnings per share (EPS) of 26 cents in the second quarter of fiscal 2017, down 42.2% year over year.

                Steris (STE) Q3 Dismal: Earnings Miss Estimates, View Cut

                Steris Plc (STE) reported third-quarter fiscal 2017 adjusted earnings per share (EPS) of 98 cents, in line with the year-ago quarter.

                  Haemonetics (HAE) Beats Q3 Earnings & Revenue Estimates

                  Haemonetics Corporation (HAE) reported adjusted earnings per share (EPS) of 43 cents in the third quarter of fiscal 2017, beating the Zacks Consensus Estimate by 7.5%.

                    Cardinal Health (CAH) Q2 Earnings Beat Estimates, Rise Y/Y

                    Cardinal Health Inc. (CAH) reported second-quarter fiscal 2017 adjusted earnings of $1.34 per share, which beat the Zacks Consensus Estimate of $1.24 and increased 3% on a year-over-year basis.

                      Phirbo Animal (PAHC) Tops Q2 Earnings, Reaffirms FY17 View

                      Phibro Animal Health Corporation (PAHC) reported adjusted earnings per share (EPS) of 39 cents in the second quarter of fiscal 2017.

                        Strength Seen in Bovie Medical (BVX): Stock Moves 5% Higher

                        Bovie Medical Corporation (BVX) was a big mover last session, as the company saw its shares rise around 5% on the day.

                          QIAGEN (QGEN) Earnings Meet, Sales Miss Estimates in Q4

                          QIAGEN N.V. (QGEN) reported fourth-quarter 2016 adjusted earnings per share (excluding restructuring expenses) of 39 cents, up 7.7% year over year.

                            IDEXX Laboratories (IDXX) Q4 Earnings Rise; Tweaks View

                            IDEXX Laboratories Inc. (IDXX) recorded fourth-quarter 2016 earnings per share (EPS) of 58 cents, up 21% year over year on a reported basis.

                              Becton, Dickinson (BDX) Beats on Q1 Earnings & Revenues

                              Becton, Dickinson and Company (BDX) reported first-quarter fiscal 2017 earnings of $2.33 per share, which beat the Zacks Consensus Estimate by 22 cents and increased from $1.96 posted in the year-ago quarter.

                                Boston Scientific (BSX) Tops Q4 Earnings, Offers 2017 View

                                Boston Scientific Corporation (BSX) posted adjusted earnings per share (EPS) of 30 cents, up 15.4% from the year-ago adjusted number.

                                  Hologic (HOLX) Beats on Q1 Earnings, Lowers '17 Guidance

                                  Hologic Inc. (HOLX) reported first-quarter fiscal 2017 adjusted earnings per share (EPS) of 52 cents, up 13% year over year.

                                    Edwards Lifesciences (EW) Beats on Earnings & Sales in Q4

                                    Edwards Lifesciences Corp. (EW) reported fourth-quarter 2016 adjusted earnings per share (EPS) of 75 cents, which surpassed the Zacks Consensus Estimate by 5.6%.

                                      Accuray (ARAY) Incurs Wider Loss in Q2, Misses on Revenue

                                      Accuray Inc. (ARAY) reported a loss of 11 cents per share in the second quarter of fiscal 2017, wider than the Zacks Consensus Estimate of a loss of 7 cents.

                                        Align Technology (ALGN) Q4 Earnings and Revenues in Line

                                        Align Technology Inc. (ALGN) reported adjusted earnings of 67 cents per share in the fourth quarter of 2016, up 11.6% from 60 cents in the year-ago quarter.

                                          Illumina (ILMN) Beats Q4 Earnings & Revenues, Guides 2017

                                          Illumina Inc. (ILMN) reported adjusted earnings per share (EPS) of 85 cents in the fourth quarter of 2016, which exceeded the Zacks Consensus Estimate by 4.9%.

                                            Zimmer Biomet (ZBH) Beats on Q4 Earnings, Knees Improve

                                            Zimmer Biomet Holdings, Inc. (ZBH) reported fourth-quarter 2016 adjusted earnings per share (EPS) of $2.14, up 2.4% year over year.

                                              AmerisourceBergen (ABC) Q1 Earnings Beat, Revenues Lag

                                              AmerisourceBergen Corporation (ABC) posted earnings (excluding one-time items) of $1.36 per share in the first quarter of fiscal 2017, beating the Zacks Consensus Estimate of $1.24.

                                                Hill-Rom TruSystem 3000 Table Boosts Surgical Solution Suite

                                                Hill-Rom Holdings (HRC) recently launched TruSystem 3000 Mobile Operating Table to fulfill hospitals' need to equip operating rooms with quality medical devices at a reasonable cost.

                                                  Thermo Fisher (TMO) Q4 Earnings Beat, Organic Sales Flat

                                                  Thermo Fisher Scientific, Inc. (TMO) reported better-than-expected fourth-quarter and full-year 2016 earnings results.